Your browser doesn't support javascript.
loading
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study.
Levy, C; Dognon, N; Normandin, S; Duburcq, T; Gaudet, A; Parmentier-Decrucq, Erika; Poissy, Julien; Dubucquoi, Sylvain; Boddaert, Pauline; Caplan, Morgan; Goutay, Julien; Durand, Arthur; Graffin, Benoit; Gaudel, Myrtille; Detollenaere, Charles; Gueguen, Ines; Ceunebroek, Marine Van; Tortuyaux, Romain; Saura, Ouriel; Kalioubie, Ahmed El; Favory, Raphael; Girardie, Patrick; Houard, Marion; Jaillette, Emmanuelle; Jourdain, Mercedes; Ledoux, Geoffrey; Mathieu, Daniel; Moreau, Anne Sophie; Nseir, Saad; Onimus, Thierry; Preau, Sebastien; Robriquet, Laurent; Rouze, Anahita; Six, Sophie; Soquet, Jerome; Loobuyck, Valentin; Mugnier, Agnes; Vincentelli, André.
Afiliación
  • Levy C; Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
  • Dognon N; University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France.
  • Normandin S; CHU Lille, Immunology Institute, F-59000 Lille, France.
  • Duburcq T; University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
  • Gaudet A; Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
  • Parmentier-Decrucq E; University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
  • Poissy J; Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
  • Dubucquoi S; University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France.
  • Boddaert P; CHU Lille, Immunology Institute, F-59000 Lille, France.
  • Caplan M; University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
  • Goutay J; Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
  • Durand A; University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France.
  • Graffin B; CHU Lille, Immunology Institute, F-59000 Lille, France.
  • Gaudel M; University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
  • Detollenaere C; Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
  • Gueguen I; University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France.
  • Ceunebroek MV; CHU Lille, Immunology Institute, F-59000 Lille, France.
  • Tortuyaux R; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, F-59000 Lille, France.
  • Saura O; University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
Med Intensiva ; 47(1): 51-54, 2023 Jan.
Article en En | MEDLINE | ID: mdl-35528276
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Med Intensiva Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Med Intensiva Año: 2023 Tipo del documento: Article País de afiliación: Francia